Govindan Rajamohan | |
---|---|
Born | India |
Nationality | Indian |
Known for | Studies on healthcare related infections |
Awards |
|
Scientific career | |
Fields | |
Institutions |
Govindan Rajamohan (born 1970) is an Indian molecular microbiologist, biotechnologist and a Chief scientist at the CSIR-Institute of Microbial Technology. [1] He is known for his research on healthcare related infections with special emphasis on Acinetobacter, Klebsiella, ESKAPE, Human microbiome and Thrombolysis. [2] His studies have been documented by way of a number of articles [note 1] and ResearchGate, an online repository of scientific articles has listed 21 of them. [3] The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2013. [4]
Beta-lactamases (β-lactamases) are enzymes produced by bacteria that provide multi-resistance to beta-lactam antibiotics such as penicillins, cephalosporins, cephamycins, monobactams and carbapenems (ertapenem), although carbapenems are relatively resistant to beta-lactamase. Beta-lactamase provides antibiotic resistance by breaking the antibiotics' structure. These antibiotics all have a common element in their molecular structure: a four-atom ring known as a beta-lactam (β-lactam) ring. Through hydrolysis, the enzyme lactamase breaks the β-lactam ring open, deactivating the molecule's antibacterial properties.
Klebsiella pneumoniae is a Gram-negative, non-motile, encapsulated, lactose-fermenting, facultative anaerobic, rod-shaped bacterium. It appears as a mucoid lactose fermenter on MacConkey agar.
Klebsiella is a genus of Gram-negative, oxidase-negative, rod-shaped bacteria with a prominent polysaccharide-based capsule.
Multiple drug resistance (MDR), multidrug resistance or multiresistance is antimicrobial resistance shown by a species of microorganism to at least one antimicrobial drug in three or more antimicrobial categories. Antimicrobial categories are classifications of antimicrobial agents based on their mode of action and specific to target organisms. The MDR types most threatening to public health are MDR bacteria that resist multiple antibiotics; other types include MDR viruses, parasites.
Tigecycline, sold under the brand name Tygacil, is a tetracycline antibiotic medication for a number of bacterial infections. It is a glycylcycline class drug that is administered intravenously. It was developed in response to the growing rate of antibiotic resistant bacteria such as Staphylococcus aureus, Acinetobacter baumannii, and E. coli. As a tetracycline derivative antibiotic, its structural modifications has expanded its therapeutic activity to include Gram-positive and Gram-negative organisms, including those of multi-drug resistance.
The genus Raoultella is composed of Gram-negative, oxidase-negative, aerobic, nonmotile, capsulated, facultatively anaerobic rods in the family Enterobacteriaceae. It is named after the French bacteriologist Didier Raoult. The existence of this genus renders the genus Klebsiella paraphyletic, and it has been repeatedly proposed to consider Raoultella a junior synonym of Klebsiella.
Multidrug resistant Gram-negative bacteria are a type of Gram-negative bacteria with resistance to multiple antibiotics. They can cause bacteria infections that pose a serious and rapidly emerging threat for hospitalized patients and especially patients in intensive care units. Infections caused by MDR strains are correlated with increased morbidity, mortality, and prolonged hospitalization. Thus, not only do these bacteria pose a threat to global public health, but also create a significant burden to healthcare systems.
Carbapenem-resistant Enterobacteriaceae (CRE) or carbapenemase-producing Enterobacteriaceae (CPE) are Gram-negative bacteria that are resistant to the carbapenem class of antibiotics, considered the drugs of last resort for such infections. They are resistant because they produce an enzyme called a carbapenemase that disables the drug molecule. The resistance can vary from moderate to severe. Enterobacteriaceae are common commensals and infectious agents. Experts fear CRE as the new "superbug". The bacteria can kill up to half of patients who get bloodstream infections. Tom Frieden, former head of the Centers for Disease Control and Prevention has referred to CRE as "nightmare bacteria". Examples of enzymes found in certain types of CRE are KPC and NDM. KPC and NDM are enzymes that break down carbapenems and make them ineffective. Both of these enzymes, as well as the enzyme VIM have also been reported in Pseudomonas.
The Community for Open Antimicrobial Drug Discovery (CO-ADD) is a not-for-profit initiative created in 2015 reaching out to chemists in academia and research organisations who have compounds that were not designed as antibiotics and would not otherwise be screened for antimicrobial activity. These academic compounds are screened against a key panel of drug-resistant bacterial strains -superbugs. Multi-drug resistant microbes are a serious health treat, and exploration of novel chemical diversity is essential to find new antibiotics.
Balasubramanian Gopal is an Indian structural biologist, molecular biophysicist and a professor at the Molecular Biophysics Unit of the Indian Institute of Science. He is known for his studies on cell wall synthesis in Staphylococcus aureus and is an elected fellow of the National Academy of Sciences, India, Indian National Science Academy and the Indian Academy of Sciences. He received the National Bioscience Award for Career Development of the Department of Biotechnology in 2010. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 2015, for his contributions to biological sciences.
Srinivasan Ramachandran is an Indian biologist, bioinformatician and a senior principal scientist at the department of genome analysis of the Institute of Genomics and Integrative Biology. Known for his studies in the field of data analytics, Ramachandran is also an adjunct faculty, senior Principal Scientist and AcSIR Professor at the Faculty of Biological Sciences of the Indian Institute of Technology, Delhi. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences in 2007.
Nagasuma Chandra is an Indian structural biologist, biochemist and a professor at the department of biochemistry of the Indian Institute of Science. She is known for her studies on Mycobacterium tuberculosis. The Department of Biotechnology of the Government of India awarded her the National Bioscience Award for Career Development, one of the highest Indian science awards, for her contributions to biosciences in 2008.
Sujata Sharma is an Indian structural biologist, biophysicist, writer and a professor at the Department of Biophysics of the All India Institute of Medical Sciences, Delhi. She is known for her studies in the fields of protein structure, drug design and drug resistance of bacteria. Her studies have been documented by way of a number of articles and ResearchGate, an online repository of scientific articles has listed 167 of them. She is also the author of the books, "Warriors in White", an autobiographical account of some COVID-19 Warriors at All India Institute of Medical Sciences, Delhi and other leading hospitals of India, including Prof Randeep Guleria, using a combination of modern medicine, astronomy and Vedic astrology, "The Secret of the Red Crystals", an autobiographical account of her days in AIIMS Delhi. and "A Dragonfly's purpose", which is an autobiographical account of her recovery from an autoimmune disease, Guillain Barre Syndrome. The Department of Biotechnology of the Government of India awarded her the National Bioscience Award for Career Development, one of the highest Indian science awards, for her contributions to biosciences, in 2011. She is also a recipient of the Woman Scientist Award of the Biotech Research Society of India and the National Young Woman Bioscientist Award of the Department of Biotechnology which she received in 2006 and 2007 respectively. In 2020, she was awarded the Kalpana Chawla Excellence award, for her contributions in science. This award is instituted in the memory of the first Indian woman astronaut, Kalpana Chawla to go on space missions.
Dibyendu Sarkar is an Indian biochemist, molecular microbiologist and a Chief Scientist at the Institute of Microbial Technology. He is known for his studies on Mycobacterium tuberculosis (Mtb), the bacterial pathogen causing the disease of tuberculosis. His studies have been documented by way of a number of articles and Google Scholar, an online repository of scientific articles has listed 23 of them. He has also delivered invited speeches which included the Second Annual Meeting on Infectious Diseases held at the Indian Institute of Science in September 2017. He is an elected member of Guha Research Conference and a recipient of the Raman Research Fellowship of the Council of Scientific and Industrial Research. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2011.
Asad Ullah Khan is an Indian microbiologist, biochemist and a professor at the Interdisciplinary Biotechnology Unit of the Aligarh Muslim University. He is known for his studies on multidrug resistant clinical strains as well as for the first sighting in India of Aligarh super bug (NDM-4), a variant of New Delhi metallo-beta-lactamase 1 (NDM-1). He is an elected fellow of the Royal Society of Chemistry, the Biotech Research Society, India and the Indian Academy of Microbiological Sciences. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2012.
Aditya Bhushan Pant is an Indian toxicologist, neurobiologist and a scientist at the Indian Institute of Toxicology Research. He is known for his studies in the fields of developmental toxicology, in vitro experiments as well as pesticides and is a member of the Neurobiology Task force of the Department of Biotechnology. His studies have been documented by way of a number of articles and ResearchGate, an online repository of scientific articles has listed 121 of them. Besides, he has contributed chapters to books published by others and is an associate editor of the Annals of Neurosciences journal of the Indian Academy of Neurosciences. He is a recipient for the Shakuntala Amir Chand Prize of the Indian Council of Medical Research in 2007. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2012.
Hirekodathakallu Venkataramaiah Thulasiram is an Indian bioorganic chemist, chemical biologist and a principal scientist at the National Chemical Laboratory of the Council of Scientific and Industrial Research. he is known for his studies in the fields of biocatalysis and organic synthesis, specifically on isoprenoid biosynthesis. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2015.
Professor Pravindra Kumar is an Indian biophysicist, bioinformatician, biochemist and Professor & Head Department of Biosciences and Bioengineering, Indian Institute Of Technology–Roorkee (IIT–Roorkee) India. He is known for his work on protein-protein interactions, protein engineering and structure-based drug design. Prof. Pravindra Kumar's primary research interest lies in studying Bacterial enzymes and pathways involved in the degradation of toxic aromatic compounds, such as PCBs, dibenzofuran, chlorodibenzofurans, DDT, dyes, and plastics/plasticizers. He focuses particularly on oxidoreductases enzymes due to their unique ability to catalyze challenging reactions, with a special emphasis on understanding their catalytic mechanisms and structural basis for guiding protein engineering. One notable achievement of his research group is the successful engineering of dioxygenases capable of metabolizing various toxic compounds, including those found in plastics.
Prabhu B. Patil is an Indian bacterial geneticist and a senior scientist at the Institute of Microbial Technology. Known for his studies on bacterial genetics, genomics and metagenomics, Patil has published his research findings by way of a number of articles; ResearchGate, an online repository of scientific articles has listed 95 of them. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2017–18.